Patients' Characteristics and Percentage of CD38++ Plasma Cells Expressing Surface MHC (HLA), Signaling or Costimulatory Molecules, and CD19 Antigen
Patient . | Age (yr)/Sex . | Clinical . | Monoclonal . | % PC . | % of CD38++ Plasma Cells Expressing . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
No. . | . | Stage . | Ig . | in BM . | DR . | DQ . | ABC . | CD40 . | CD80 . | CD86 . | CD19 . |
1 | 72/F | IIA | IgGλ | 42 | 11.6 | 23.3 | 99.5 | ND | ND | ND | ND |
2 | 72/F | IA | IgG1κ | 22 | 44.0 | 7.8 | 96.9 | 6.4 | 1.7 | 4.9 | 1.3 |
3 | 70/M | IIIB | IgG1κ | 70 | 13.4 | ND | 99.0 | 64.0 | 3.9 | 5.5 | 0.2 |
4 | 55/M | IA | IgG1κ | 28 | 10.0 | 20.1 | 99.8 | 3.6 | 9.7 | 20.0 | 0.7 |
5 | 67/M | IIA | IgAκ | 56 | 33.2 | 8.4 | 97.8 | 2.2 | 1.6 | 12.0 | 0.8 |
6 | 60/M | IIA | IgG1λ | 25 | 12.6 | 5.8 | 100 | 21.2 | 3.8 | 18.2 | 1.0 |
7 | 89/F | IA | IgG1κ | 19 | 22.7 | 7.7 | 98.0 | 3.5 | 2.0 | 11.0 | 1.0 |
8 | 66/M | IA | IgAκ | 18 | 9.2 | 10.0 | 96.9 | 24.3 | 3.5 | 15.4 | 0.3 |
Median | 69/ — | — | — | 28 | 12.5 | 8.4 | 98.5 | 6.4 | 3.5 | 12.0 | 0.7 |
Patient . | Age (yr)/Sex . | Clinical . | Monoclonal . | % PC . | % of CD38++ Plasma Cells Expressing . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
No. . | . | Stage . | Ig . | in BM . | DR . | DQ . | ABC . | CD40 . | CD80 . | CD86 . | CD19 . |
1 | 72/F | IIA | IgGλ | 42 | 11.6 | 23.3 | 99.5 | ND | ND | ND | ND |
2 | 72/F | IA | IgG1κ | 22 | 44.0 | 7.8 | 96.9 | 6.4 | 1.7 | 4.9 | 1.3 |
3 | 70/M | IIIB | IgG1κ | 70 | 13.4 | ND | 99.0 | 64.0 | 3.9 | 5.5 | 0.2 |
4 | 55/M | IA | IgG1κ | 28 | 10.0 | 20.1 | 99.8 | 3.6 | 9.7 | 20.0 | 0.7 |
5 | 67/M | IIA | IgAκ | 56 | 33.2 | 8.4 | 97.8 | 2.2 | 1.6 | 12.0 | 0.8 |
6 | 60/M | IIA | IgG1λ | 25 | 12.6 | 5.8 | 100 | 21.2 | 3.8 | 18.2 | 1.0 |
7 | 89/F | IA | IgG1κ | 19 | 22.7 | 7.7 | 98.0 | 3.5 | 2.0 | 11.0 | 1.0 |
8 | 66/M | IA | IgAκ | 18 | 9.2 | 10.0 | 96.9 | 24.3 | 3.5 | 15.4 | 0.3 |
Median | 69/ — | — | — | 28 | 12.5 | 8.4 | 98.5 | 6.4 | 3.5 | 12.0 | 0.7 |
Abbreviations: PC, plasma cells; BM, bone marrow; ND, not done.